BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4734402)

  • 1. Binding of antigen by immunocytes. I. Effect of ligand valence on binding affinity of MOPC 315 cells for DNP conjugates.
    Bystryn JC; Siskind GW; Uhr JW
    J Exp Med; 1973 Feb; 137(2):301-16. PubMed ID: 4734402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of antigen by immunocytes. II. Effect of specific Ig on antigen binding by MOPC 315 cells.
    Bystryn JC; Siskind GW; Uhr JW
    J Exp Med; 1975 Jun; 141(6):1227-37. PubMed ID: 1168694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand-induced redistribution and augmentation of surface-bound myeloma protein on MOPC 315 plasmacytoma cells.
    Hannestad K; Gaudernack G
    Scand J Immunol; 1977; 6(1-2):59-76. PubMed ID: 403594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of immunity and tolerance in vitro by hapten protein conjugates. 3. Hapten inhibition studies of antigen binding to B cells in immunity and tolerance.
    Feldmann M
    J Exp Med; 1972 Sep; 136(3):532-45. PubMed ID: 5065753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface immunoglobulins of lymphocytes in plasmacytoma. V. The effect of RNA-rich extract from mouse plasmacytoma MOPC 104E on the immune response.
    Bhoopalam N; Chen Y; Yakulis V; Heller P
    Clin Exp Immunol; 1976 May; 24(2):357-67. PubMed ID: 1277583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new T cell neoplasm expressing surface anti-DNP activity, developed from the thymus of mice bearing MOPC-315 plasma cell tumors.
    Lahat N; Moroz C
    Adv Exp Med Biol; 1976; 66():477-81. PubMed ID: 1083649
    [No Abstract]   [Full Text] [Related]  

  • 7. Effector cell blockade. A new mechanism of immune hyporeactivity induced by multivalent antigens.
    Schrader JW; Nossal GJ
    J Exp Med; 1974 Jun; 139(6):1582-98. PubMed ID: 4133616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immune response against hapten-autologous protein conjugates in the mouse.
    Rubin B; Wigzell H
    J Exp Med; 1973 Apr; 137(4):911-31. PubMed ID: 4540327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of dissociation constants and ligand specificity of detergent solubilized surface membrane immunoglobulin A from MOPC-315.
    Jarvis MR; Voss EW
    Mol Immunol; 1983 Jan; 20(1):125-36. PubMed ID: 6855776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptors on immunocompetent cells. IV. Direct measurement of avidity of cell receptors and cooperative binding of multivalent ligands.
    Davie JM; Paul WE
    J Exp Med; 1972 Mar; 135(3):643-59. PubMed ID: 5061978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-bound myeloma proteins on the surface of myeloma cells: potential targets for the immune system.
    Hannestad K; Kao MS; Eisen HN
    Proc Natl Acad Sci U S A; 1972 Aug; 69(8):2295-9. PubMed ID: 4626403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of antigen-bearing fluorescent liposomes to the murine myeloma tumor MOPC 315.
    Leserman LD; Weinstein JN; Blumenthal R; Sharrow SO; Terry WD
    J Immunol; 1979 Feb; 122(2):585-91. PubMed ID: 368242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of cell-surface antigenicity of the mouse plasmacytoma. II. Lack of correlation between synthesis of myeloma protein and alteration of surface antigen.
    Ohno S; Natsu-ume-Sakai S; Migita S
    J Natl Cancer Inst; 1977 Feb; 58(2):229-37. PubMed ID: 833874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of antibody production in plasmacytoma cells by antigen.
    Abbas AK; Klaus GG
    Eur J Immunol; 1977 Oct; 7(10):667-74. PubMed ID: 73462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional examination of hapten-binding derivatives from a murine myeloma protein with immunoglobulin features.
    Merz DC; Litman GW; Good RA
    Proc Natl Acad Sci U S A; 1974 May; 71(5):1940-4. PubMed ID: 4525470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The specific cytotoxic effects of daunomycin conjugated to antitumor antibodies.
    Levy R; Hurwitz E; Maron R; Arnon R; Sela M
    Cancer Res; 1975 May; 35(5):1182-6. PubMed ID: 164280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of immunity and tolerance in vitro by hapten protein conjugates. I. The relationship between the degree of hapten conjugation and the immunogenicity of dinitrophenylated polymerized flagellin.
    Feldmann M
    J Exp Med; 1972 Apr; 135(4):735-53. PubMed ID: 5062922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of antibody production in plasmacytoma cells. III. Interactions of suppressive and nonsuppressive DNP conjugates with MOPC 315 cells.
    Abbas AK
    J Immunol; 1979 May; 122(5):1791-7. PubMed ID: 87442
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of murine plasmocytoma tumours with antibody activity by their respective specific antigens.
    Paraf A; Guérin-Marchand C; Aubry J; Dubert JM
    Ann Immunol (Paris); 1975; 126C(4):411-21. PubMed ID: 55094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloma proteins with anti-hapten antibody activity: epsilon-2,4-dinitrophenyl lysine binding by the protein produced by mouse plasmacytoma MOPC-460.
    Jaffe BM; Eisen HN; Simms ES; Potter M
    J Immunol; 1969 Oct; 103(4):872-4. PubMed ID: 5349739
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.